Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Stem Cell Market From 2025 To 2029?

The expansion of the stem cell market has been significant over the past few years. The current market value of $15.34 billion in 2024 is expected to accelerate to $16.85 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.8%. The remarkable growth during this historical period is linked with the progress in the field of regenerative medicine, the increasing instances of chronic illnesses, ongoing research and development ventures, the overall increase in the aged population, as well as the elevated levels of awareness and acceptance.

What Is the Projected Market Size of the Stem Cell Market?

Expectations are high for the stem cell market to experience rapid expansion in the coming years, with estimates projecting it to reach a figure of $25.92 billion by 2029, boasting a compound annual growth rate (CAGR) of 11.4%. This significant uptick within the forecast period can be credited to numerous contributory factors, including a wider range of applications in oncology, revolutionary advances in personalized medicine, the backing and funding provided by the government, collaborations and partnerships within biotechnology, advancements in clinical trials, and regulatory approvals. Additionally, several major trends are anticipated during the forecast period, such as the commercialization of stem cell treatments, application of the cutting-edge CRISPR technology, development of regulatory structures, investment into stem cell research, along with increased attention on exosome therapeutics.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2584&type=smp

Who are the Major Competitors in the Stem Cell Market Outlook?

Major companies operating in the stem cell market include Danaher Corporation, Cryo-Cell International Inc., Daiichi Sankyo Company Limited, Lonza Group Ltd, PerkinElmer Inc., CellGenix GmbH, China Cord Blood Corporation, Organogenesis Holdings Inc., LifeCell International, Cord Blood America Inc., StemCyte Inc., Cryoviva India, Cordlife Group Limited, Thermo Fisher Scientific Inc., CordVida, Cryo Stemcell Inc., Pluristem Therapeutics Inc., Mesoblast Limited, Americord Registry LLC, Smart Cells International, Athersys Inc., ReeLabs Pvt. Ltd., Cytori Therapeutics Inc., Esperite N.V., Stemade Biotech, ViaCord, Aldagen Inc, Isto Biologics, Brainstorm Cell Therapeutics Inc.

What Is Fueling Growth in the Stem Cell Market?

The rise in Chronic diseases globally is propelling the growth of the Stem cell market. Stem-cell therapy, which involves the use of stem cells to address or prevent a medical condition or disease, is becoming increasingly popular. Bone marrow transplant is the most commonly seen stem-cell therapy, although treatments based on umbilical cord blood are also utilized. Presently, the most prevalent stem cell treatment involves the transplantation of blood stem cells to remedy diseases or conditions impacting the blood and immune system or to rejuvenate the blood system post treatments for particular cancers. For example, Allergy UK, a nationwide charity based in the UK, reported in April 2024 that over 21 million people in the UK are living with allergies. This disorder became the most frequently reported chronic health condition in 2022, and forecasts suggest that by 2026, half of Europe’s population will suffer from at least one allergy. Consequently, the growing prevalence of chronic diseases globally fuels the expansion of the stem cell market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2584&type=smp

Which Stem Cell Market Segments Are Growing the Fastest?

The stem cell market covered in this report is segmented –

1) By Source: Autologous, Allogeneic

2) By Product Type: Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell, Other Products

3) By Application: Regenerative Medicine, Drug Discovery And Development

Subsegments:

1) By Autologous: Bone Marrow-Derived Stem Cells, Adipose Tissue-Derived Stem Cells, Peripheral Blood Stem Cells

2) By Allogeneic: Bone Marrow-Derived Stem Cells, Umbilical Cord Blood Stem Cells, Peripheral Blood Stem Cells From Donors

Which Industry Trends Are Shaping the Future of the Stem Cell Market?

Firms operating within the stem cell therapeutics market are honing their focus on the invention and enhancement of new technologies such as Induced Pluripotent Stem Cells (IPSC) to elevate the effectiveness of stem cell therapies. IPSC are harvested from blood or skin cells, which are then reprogrammed to a state akin to that of embryonic cells after incorporating essential genes which are responsible for maintaining crucial properties and promoting unlimited growth of any human cell type necessary for stem cell therapeutic interventions. The production of these IPSC’s doesn’t involve the use of human embryos, thereby eliminating any bioethical controversies and paving the way for scientists to secure federal funding and backing with ease. The Japanese firm, Oksara, has established a medical center dedicated to the production of cells obtained from iPS Cells. In a related vein, Takar Bio has introduced human iPSC derived Beta Cells, known as Cellartis, for disease modeling and the discovery of drugs.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report

Which Countries Are Leading the Stem Cell Market?

The countries covered in the stem cell market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2584

This Report Delivers Insight On:

1. How big is the stem cell market, and how is it changing globally?

2. Who are the major companies in the stem cell market, and how are they performing?

3. What are the key opportunities and risks in the stem cell market right now?

4. Which products or customer segments are growing the most in the stem cell market?

5. What factors are helping or slowing down the growth of the stem cell market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model